Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBasetez oradaEkotizim uchun ochiq API
Lotin
Oʻzbek
Maqola

New Self-Reporting Questionnaire to Assess Urinary Tract Infections and Differential Diagnosis: Acute Cystitis Symptom Score

Jakhongir F. AlidjanovRepublican Specialized Center of Urology, Tashkent, UzbekistanUlugbek A. AbdufattaevRepublican Specialized Center of Urology, Tashkent, UzbekistanSaidamin A. MakhsudovRepublican Specialized Center of Urology, Tashkent, UzbekistanAdrian PilatzClinic of Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, GermanyF.A. AkilovRepublican Specialized Center of Urology, Tashkent, UzbekistanKurt G. NaberTechnical University of Munich, Munich, andFlorian WagenlehnerClinic of Urology, Pediatric Urology and Andrology, Justus Liebig University, Giessen, Germany
Urologia Internationalisjournal2014en
ABI

Annotatsiya

OBJECTIVE: Development and validation of a simple and standardized self-reporting questionnaire for acute uncomplicated cystitis (AUC) assessing typical and differential symptoms, quality of life and possible changes after therapy in female patients with AUC. MATERIALS AND METHODS: Literature research, development and evaluation of the Acute Cystitis Symptom Score (ACSS), an 18-item self-reporting questionnaire including (a) six questions about 'typical' symptoms of AUC, (b) four questions regarding differential diagnoses, (c) three questions on quality of life and (d) five questions on additional conditions which may affect therapy. The ACSS was evaluated in 286 women (mean age 32.3 ± 12.3 years) in the Russian and Uzbek language. Measurements of reliability, validity, predictive ability and responsiveness were performed. RESULTS: Cronbach's alpha for the ACSS was 0.89, split-half reliability was 0.92 and correlation between halves was 0.85. Mann-Whitney test revealed significant difference scores of the 'typical' domain between patients and controls (10.75 vs. 2.02, p < 0.001). The optimal threshold score was 6 points, with a 94% sensitivity and 90% specificity to predict AUC. The symptom score decreased significantly when comparing before and after therapy (10.7 vs. 2.1, p < 0.001). CONCLUSION: The new validated ACSS is accurate enough and can be recommended for clinical studies and practice for initial diagnosis and monitoring treatment of AUC. Evaluation in other languages is in progress.

Mavzular

Identifikatorlar

Iqtiboslar va manbalar

Koʻrsatkichlar — AkademScholar · Tez orada